Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Martha Patricia Sierra-Vargas
 -- 2898 2023-02-01 05:36:52 |
2 format correct
Jessie Wu
 Meta information modification 2898 2023-02-02 01:56:43 | |
3 format correct
Jessie Wu
 Meta information modification 2898 2023-02-02 02:01:27 |

Video Upload Options

Do you have a full video?
Send video materials Upload full video

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Sierra-Vargas, M.P.;  Montero-Vargas, J.M.;  Debray-García, Y.;  Vizuet-De-Rueda, J.C.;  Loaeza-Román, A.;  Terán, L.M. Air Pollution on Chronic Rhinosinusitis and Asthma. Encyclopedia. Available online: https://encyclopedia.pub/entry/40703 (accessed on 20 April 2024).
Sierra-Vargas MP,  Montero-Vargas JM,  Debray-García Y,  Vizuet-De-Rueda JC,  Loaeza-Román A,  Terán LM. Air Pollution on Chronic Rhinosinusitis and Asthma. Encyclopedia. Available at: https://encyclopedia.pub/entry/40703. Accessed April 20, 2024.
Sierra-Vargas, Martha Patricia, Josaphat Miguel Montero-Vargas, Yazmín Debray-García, Juan Carlos Vizuet-De-Rueda, Alejandra Loaeza-Román, Luis M. Terán. "Air Pollution on Chronic Rhinosinusitis and Asthma" Encyclopedia, https://encyclopedia.pub/entry/40703 (accessed April 20, 2024).
Sierra-Vargas, M.P.,  Montero-Vargas, J.M.,  Debray-García, Y.,  Vizuet-De-Rueda, J.C.,  Loaeza-Román, A., & Terán, L.M. (2023, February 01). Air Pollution on Chronic Rhinosinusitis and Asthma. In Encyclopedia. https://encyclopedia.pub/entry/40703
Sierra-Vargas, Martha Patricia, et al. "Air Pollution on Chronic Rhinosinusitis and Asthma." Encyclopedia. Web. 01 February, 2023.
Air Pollution on Chronic Rhinosinusitis and Asthma
Edit
This entry is adapted from the peer-reviewed paper 10.3390/ijms24010853

Redox regulation participates in the control of various aspects of metabolism. Reactive oxygen and nitrogen species participate in many reactions under physiological conditions. When these species overcome the antioxidant defense system, a distressed status emerges, increasing biomolecular damage and leading to functional alterations. Air pollution is one of the exogenous sources of reactive oxygen and nitrogen species. Ambient airborne particulate matter (PM) is important because of its complex composition, which includes transition metals and organic compounds. Once in contact with the lungs’ epithelium, PM components initiate the synthesis of inflammatory mediators, macrophage activation, modulation of gene expression, and the activation of transcription factors, which are all related to the physiopathology of chronic respiratory diseases, including cancer. 

respiratory diseases air pollution

1. Introduction

In the cell’s metabolic process, reactive oxygen and nitrogen species (ROS/RNS) are produced, which have high reactivity; they are free radicals. Free radicals come from redox reactions, radiolysis, photolysis, and hemolytic fission, where chemical bonds break and each newly created fragment preserves one of the bounded initial electrons [1]. Even though they are reactive molecules, they also contribute to different cellular processes, such as protein phosphorylation, secondary messengers, the activation of transcription factors, immune responses, and apoptosis. The cellular organelles that contribute to the endogen generation of ROS/RNS are the mitochondria, through the electron transport chain that produces the primary ROS, the superoxide anion radical (O2•−), which can further interact with other molecules to generate secondary ROS such as hydrogen peroxide (H2O2) and the hydroxyl radical (HO•). Peroxisomes produce H2O2 under physiological conditions, and nicotine adenine dinucleotide phosphate (NAD(P)H) oxidase in phagocytes generates O2•− through respiratory bursts to destroy bacteria [2]. In parallel, RNS are also mainly produced under hypoxic conditions that activate the nitric oxide synthases in the mitochondria and phagocytic cells during respiratory bursts. Moreover, Toll-like receptors (TLR) such as TLR1, 2, and 4 can produce ROS by recruiting mitochondria to macrophage phagosomes [3].
All those mechanisms are driven at the physiological level of ROS/RNS, known as oxidative eustress. Cellular antioxidant mechanisms maintain eustress, and when the formation of ROS/RNS overwhelms the cell’s antioxidant defense, molecular damage is produced, characterized as oxidative stress or distress [4]. Exogenous factors contributing to the generation of ROS/RNS include exposure to environmental pollutants, such as heavy metals (Cd, Hg, Pb, Fe, and As), certain drugs (cyclosporine, tacrolimus, gentamycin, and bleomycin), chemical solvents, cooking (smoked meat, used oil, and fat), cigarette smoke, vaping, alcohol, and radiation [5]. There is growing evidence that air pollution enhances oxidative stress and contributes to several diseases, from airway illnesses to DNA damage [6]. The participation of oxidative stress in the pathophysiology of respiratory tract diseases is shown (Figure 1).
Ijms 24 00853 g001 550
Figure 1. Oxidative stress activates the lungs’ epithelial cells, generating inflammatory mediators that participate in the macrophage activation and the modulation of gene expression and transcription factors. All of them are implicated in numerous respiratory diseases.

2. Chronic Rhinosinusitis (CRS) and Nasal Polyps (NP)

Chronic rhinosinusitis (CRS) is a chronic inflammation of the nose and paranasal sinuses, with a wide range of clinical phenotypes. This heterogeneous disease has an incidence of approximately 5%, significantly impacting the patients’ quality of life and productivity. One-third of the world’s population with CRS has nasal polyps (CRSwNP)  [7]. A Type 2 inflammation mediated by the mast cells is present in CRS in response to increased oxidative stress. It has been suggested that air pollution causes an inflammatory change in the respiratory epithelium associated with CRS. However, there are few studies on the impact of air pollution and oxidative stress on the development of CRS. Recently, Patel and colleagues studied the relationship between levels of particulate air pollution (PM2.5) and the pathogenesis of CRS. They found that exposure to ambient air pollutants may contribute to the pathogenesis of this disease. Ozone is another air component linked to higher tissue inflammation, eosinophilic aggregates, and Charcot–Leyden crystals in CRSwNP patients evaluated in one study [8]. Another critical aspect investigated was whether socioeconomic status and exposure to airborne pollutants such as PM2.5, black carbon (BC), and NO2 increased the disease’s severity. The results showed that lower socioeconomic status predicted higher exposure to air pollution and increased disease severity in patients with CRS [9].
A study evaluated occupational airborne exposure and the severity of CRS [10]. The impact of exposure to vapors, gases, dust, fumes, fibers, and mist on 113 patients with CRSwNP, 96 with CRS without nasal polyps (CRSsNP), and 96 patients with aspirin-exacerbated respiratory disease (AERD) were evaluated. Patients exposed to these air contaminants required higher steroid doses than nonexposed patients. Contrary to other reports, this research found that PM2.5 and BC did not have a high impact on disease severity. On the other hand, Zheng and colleagues (2020) studied the role of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in CRSwNP. This oxidase has been associated with the pathogenesis of CRSwNP. Zheng et al. found, by Western blotting and real-time PCR, that this oxidase is increased in the nasal polyps of patients. These findings suggest that oxidative stress plays a role in the pathogenesis of CRSwNP [11]. The expression level of several oxidative stress and inflammation-related genes provided valuable information on the impact of air pollution on the nasal mucosa and nasal polyps of patients with CRS.
Recently, at the molecular level, the expression of oxidative stress- and inflammation-related genes in nasal polyps from patients with CRSwNP was evaluated. A significantly lower difference in the expression levels of transcription of antioxidant enzymes, including superoxide dismutase (SOD) and peroxiredoxin-2 (PRDX2), was reported, independent of age, sex, and smoking in patients with CRSwNP [12]. These results correspond to reduced SOD capacity with the increase in oxidative stress. Additionally, an analysis of the advanced oxidation protein products (AOPP) and SOD showed the opposite effect in patients with NP. The level of AOPP from NP was higher than in the healthy control group. However, SOD activity was lower, indicating that oxidative stress plays a vital role in the development of nasal polyps [13]. Another mechanism of regulating oxidative stress is mediated by the thioredoxin-interacting protein (TXNIP), which acts as a pro-oxidant protein by suppressing the activity of thioredoxin (TRX) and its antioxidant function [14]. However, in nasal tissue samples from patients with CRSwNP, the protein and mRNA of TXNIP and TRX were significantly increased and decreased, respectively, compared with the control subjects [15].
The transcription factors (TFs) are the primary regulators of gene expression. In this sense, essential TFs are related to oxidative stress, such as nuclear erythroid 2-related factor 2 (Nrf2), which regulates several antioxidant genes. For example, Nrf2 was necessary for an antioxidant pathway in a mouse model of rhinosinusitis. Knockout mice showed enhanced severity of eosinophilic sinonasal inflammation from disruption of the epithelial-specific Nrf2 pathway [16] and enhanced susceptibility to eosinophilic sinonasal inflammation [17]. This transcription factor has also been related to the stability of the sinonasal epithelial cell barrier function [18]. Scavenger receptors (SRs) are a broad family of transmembrane receptors involved in a dysfunctional host–environment interaction through a reaction with ROS production. Lectin-like oxidized LDL receptor-1 (LOX-1) is one member of these transmembrane receptors. In 2020, Nishida and colleagues found a significant increase in the mRNA expression levels of LOX-1 in CRSwNP patients [19].
Moreover, human sinuses are the primary source of NO in the airways. NO plays a role in regulating airway inflammation through the expression of NO synthase isoforms. Oxidative damage to the cellular components occurs when excessive amounts of NO are produced. Therefore, measuring NO levels can help diagnose CRS and sinonasal inflammation [20]. Additionally, dupilumab, an anti-IL-4 receptor alpha monoclonal antibody, has been used recently in the treatment of CRSwNP. Patients with CRSwNP treated with dupilumab were evaluated through extended nitric oxide analyses (exhaled, FENO; bronchial, JawNO; alveolar, CalvNO components; nasal, nNO) where the results showed that nitric oxide significantly improved after 15 days of treatment [21].
Some patients with CRSwNP suffer from bacterial airway infection and damage to the respiratory epithelia. TAS2R38 is an essential receptor in epithelial cells; its stimulation increases the production of NO, then the NO damages bacterial membranes, enzymes, and DNA, and increases the ciliary beat frequency. The expression of TAS2R38 in the cilia of human sinonasal epithelial cells is associated with susceptibility to CRS. Patients with advanced CRSwNP showed reduced TAS2R38 receptor expression in the sinonasal mucosa [22]. Similar results were found in Italian patients with CRSwNP [23]. Another critical receptor in the epithelial cells of the human airway is the bitter taste receptor (T2Rs). T2Rs can stimulate endothelial NO synthase (eNOS), whereby NO enhances mucociliary clearance with antibacterial effects on ciliated epithelial cells [24]. This activation of T2Rs is associated with CRSwNP status and has been proposed as a biomarker [25]. Oxidation can activate the calcium-activated kinase (CaMKII); the role of this kinase has been reported in several models of asthma, CRSwNP, cardiovascular disease, diabetes mellitus, and cancer [26]. The expression of ox-CaMKII was measured in CRSwNP with other proteins such as indoleamine 2,3-dioxygenase 1, tryptophan 2,3-dioxygenase, and kynurenine. Oxidized CaMKII was increased in eosinophilic polyps [27].
Nasal polyps (NP) are a common inflammatory mass affecting from 0.2% to 5.6% of the population [28]. The etiology of NP is unclear because the factors involved in its occurrence include the genetic background, the immune system, anatomical differences, and environmental conditions. However, NP are associated with other chronic inflammatory respiratory diseases such as cystic fibrosis, AERD, respiratory allergies, and, as mentioned above, CRSwNP [29]. Epidemiologically, there is an association between air pollution and the increased prevalence of these respiratory diseases [30]. Exposure to air pollutants enhances the symptoms’ severity, resulting in an imbalanced concentration of free radicals and ROS such as NO•, HO•, O2•−, and H2O2. In this regard, some studies have explored the association of the development and pathogenesis of NP with oxidative stress and air pollution, although information is limited.
Since the nasal epithelium is the first barrier of entry for inhaled particles such as pollutants, it plays a crucial role in the formation of NP. Oxidative stress damages the epithelium and causes mucosal edema due to impaired ion transport. The intracellular Na+ increases, the Ca2+ moves into the cell, and intracellular K+ decreases [31]. Moreover, chronic exposure to air contaminants affects the concentration of H2O2 and IL-8 in the nasal epithelium, a physiological defense mechanism [32]. The increase in the cells’ permeability and the migration of inflammatory cells of the proliferative and secretory response is yet, another innate immune response mechanism. The release of cytokines by effector cells, and the activity of cyclooxygenase and lipoxygenase are also associated with the pathophysiology of NP [33].
One of the most critical lines of defense against ROS are enzymes crucial for the activity of antioxidant, such as SOD, catalase, glutathione peroxidase, and thiol reductase [13]. The expression and activity of SOD, which catalyzes the dismutation of superoxide anions, is lower in NP than in healthy mucosa, which is correlated with lower antioxidant blood levels in NP patients [34][35][36]. Different molecules are related to oxidative stress, for example, malondialdehyde (MDA) and free radicals are the products of lipid peroxidation of polyunsaturated fatty acids in cell membranes. These oxidant products have higher NP levels than control tissues [37][38]. Another compound is nitric oxide, which is released in response to inflammation. Nitric oxide is involved in antiviral and bactericidal activity but inhibits cell proliferation, DNA synthesis, and collagen production. In NP, NO• reacts with oxygen, producing peroxynitrite, which is associated with progressive epithelial injury. In patients with nasal polyposis, there is a lower concentration of NO• compared with healthy patients, which is related to the downregulation of the nitric oxide metabolism, in which dismutase is crucial for the modulation of its activity [37].
In the same way, SOD activity was decreased, and MDA increased in NP samples, as mentioned above. Another approach to studying the role of oxidative stress in NP is to examine how the apoptotic pathway is related. In 2021, Simsek and colleagues reported deficient apoptosis through the MAPK/JNK pathway in NP tissues, which may have a role in the pathogenesis and is consistent with previous reports [39].
To date, oxidative stress is increased in patients with CRSwNP. However, this condition has a multifactorial etiology, and the role of air pollution is unclear. However, airborne pollutants may contribute to the pathogenesis of these diseases through the expression of several transcription factors and receptors in sinonasal epithelial cells. Some of them have been proposed as biomarkers.

3. Asthma

Asthma is a complex condition that is heterogeneous and is characterized by the critical role of chronic airway inflammation and oxidative stress. The eosinophils, lymphocytes, neutrophils, and mast cells generate inflammatory mediators and ROS/RNS that negatively affect the redox balance [40][41]. Furthermore, these are the basis for identifying the actual Type 2 high and Type 2 low phenotypes [42]. In Type 2 asthma patients, environmental factors favor the release of alarmins from the respiratory epithelium, which induces the differentiation of naïve T cells into Th2 cells. Damaged cells release interleukins such as IL−6, IL-1β, nitric oxide (NO•), prostaglandin E2 (PGE2), and tumor necrosis factor α (TNFα); the principal marker in these patients is the sputum eosinophilia [43]. T2-low asthma patients are characterized by sputum neutrophilia secondary to the activation of the NLRP3 inflammasome and elevated IL-1β; the activation of Th1 and/or Th17 cells associated with the imbalance of Th17/Treg cells seems to play an essential role in the pathology of asthma [44]. The response to the combination of Th1, Th2, and Th17 and genetic predisposition induce permanent structural changes in T2-high and T2-low asthma patients [45][46]. The process of airway remodeling is driven by subepithelial fibrosis, thickening of the sub-basement membrane, increased airway smooth muscle mass, angiogenesis, and mucous gland hyperplasia [45].
An imbalance in the airway-reducing state is a determinant of the initiation and severity of asthma. The ability of an individual to ward off oxidative lung damage depends partly on their endogenous antioxidant systems and exogenous antioxidant intake [27]. Several groups have shown that the levels of enzymatic antioxidants such as SOD, catalase, and glutathione peroxidases, as well as heme oxygenase-1 (HO-1), thioredoxins, peroxiredoxins, and glutaredoxins, are decreased in the bronchoalveolar lavage, sputum, and serum of asthmatic patients [40][47][48].
Some factors increase the risk of the development of asthma. Among these, regular exposure through inhalation to oxidants derived from outdoor and indoor ambient air pollutants is on the list of factors that contributes to the progression of the disease [49][50][51]. Since the relationship between oxidative stress and the inflammatory response depends on each other, and genetic predisposition could modify their balance, there is interest in the role of the inflammatory process as an activator of oxidative stress [52]. Signaling pathways involving the inflammatory process and the oxidative response associated with the development of asthma are a current matter of evaluation. For example, the adenosine 5’ monophosphate-activated protein kinase (AMPK)/sirtuin 1 (Sirt1) and Nrf2/HO-1 pathway [53] and the nitrogen-activated protein kinase (MAPK) pathway that includes extracellular signal-regulated kinases (ERKs), c-Jun N-terminal kinase (JNK), and p38 [54] have been evaluated. Nrf2 potentiates the activity of the antioxidant response element (ARE) that synthesizes antioxidant proteins such as HO-1 [55]. Multiple phytochemicals involved in the immune response activate the Nrf2/HO-1 signaling axis. In this sense, the Nrf2/HO-1, NF-κB, and MAPK pathways are relevant therapeutic molecular targets in asthma [56][57][58][59][60].
The methodologies used to identify the molecular biomarkers associated with respiratory diseases are varied and range from the use of proteomics platforms to the use of real-time PCR. In 2021, Suzuki et al. evaluated the plasma proteome using an aptamer-base affinity proteomic platform (SOMAscan®) in 34 subjects with stable COPD and 51 subjects with asthma, detecting 1238 proteins within which stress markers were found, such as myeloperoxidase (MPO), heme oxygenase 2 (HMOX2), superoxide dismutase (Cu-Zn) (SOD1), peroxiredoxin-1 (PRDX1), and glutathione-S-transferase P1 (GSTP1) [61].
However, some markers are associated with oxidative stress-related cell damage, such as MDA, which can be measured by colorimetric techniques, high-performance liquid chromatography (HPLC), or LC/atmospheric pressure chemical ionization tandem mass spectrometry (LC/APCI–MS/MS). In asthmatic patients, the sputum measurement of MDA in the sputum discriminated between patients and controls with greater accuracy than the levels found in plasma, where it might be more difficult to evidence the redox imbalance due to comorbidities and lifestyle risk factors. In addition, 8-isoprostane and the oxidative DNA damage marker 8-oxo-7,8-dihydro-29-deoxyguanosine (8-OHdG) were also increased in the sputum from asthmatic patients compared with nonasthmatic controls in several studies [62].
The mitochondria are the organelles that contributes the most to the generation of reactive oxygen species, and its contribution to oxidative stress in asthma has also been evaluated. The mitochondria are also susceptible to oxidative stress; under such conditions, they undergo an adaptive response through mitochondrial biogenesis. In 2021, Carpagnano et al. determined that the mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio was a marker of mitochondrial oxidative stress in the exhaled breath condensate (EBC) of 53 patients with severe asthma, 11 patients with mild to moderate asthma, and 12 healthy subjects. They found higher levels of exhaled mtDNA/nDNA in severe asthmatic patients compared with the mild-moderate and healthy controls; this may be useful for differentiating the asthma phenotypes [63].
It is crucial to take into account that the presence of oxidative stress is a factor that triggers asthma symptoms and contributes to the severity of the disease. Moreover, oxidative stress promotes corticosteroid insensitivity by disrupting glucocorticoid receptor (GR) signaling, leading to the sustained activation of proinflammatory pathways in immune cells and the airway’s structural cells [64][65].
As already described in this section, many methodological strategies and various target molecules are related to oxidative stress. However, specific biomarkers with clinical applications in asthma have not yet been found.

References

  1. Pruchniak, M.P.; Araźna, M.; Demkow, U. Biochemistry of Oxidative Stress BT—Advances in Clinical Science; Pokorski, M., Ed.; Springer International Publishing: Cham, Switzerland, 2016; pp. 9–19. ISBN 978-3-319-21497-9.
  2. Kruk, J.; Aboul-Enein, H.Y.; Kładna, A.; Bowser, J.E. Oxidative Stress in Biological Systems and Its Relation with Pathophysiological Functions: The Effect of Physical Activity on Cellular Redox Homeostasis. Free Radic. Res. 2019, 53, 497–521.
  3. Yang, S.; Lian, G. ROS and Diseases: Role in Metabolism and Energy Supply. Mol. Cell. Biochem. 2020, 467, 1–12.
  4. Sies, H.; Jones, D.P. Reactive Oxygen Species (ROS) as Pleiotropic Physiological Signalling Agents. Nat. Rev. Mol. Cell Biol. 2020, 21, 363–383.
  5. Pizzino, G.; Irrera, N.; Cucinotta, M.; Pallio, G.; Mannino, F.; Arcoraci, V.; Squadrito, F.; Altavilla, D.; Bitto, A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017, 2017, 8416763.
  6. Mudway, I.S.; Kelly, F.J.; Holgate, S.T. Oxidative Stress in Air Pollution Research. Free Radic. Biol. Med. 2020, 151, 2–6.
  7. Sedaghat, A.R.; Kuan, E.C.; Scadding, G.K. Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors. J. Allergy Clin. Immunol. Pract. 2022, 10, 1395–1403.
  8. Patel, T.R.; Tajudeen, B.A.; Brown, H.; Gattuso, P.; LoSavio, P.; Papagiannopoulos, P.; Batra, P.S.; Mahdavinia, M. Association of Air Pollutant Exposure and Sinonasal Histopathology Findings in Chronic Rhinosinusitis. Am. J. Rhinol. Allergy 2021, 35, 761–767.
  9. Velasquez, N.; Gardiner, L.; Cheng, T.Z.; Moore, J.A.; Boudreau, R.M.; Presto, A.A.; Lee, S.E. Relationship between Socioeconomic Status, Exposure to Airborne Pollutants, and Chronic Rhinosinusitis Disease Severity. Int. Forum Allergy Rhinol. 2022, 12, 172–180.
  10. Velasquez, N.; Moore, J.A.; Boudreau, R.M.; Mady, L.J.; Lee, S.E. Association of Air Pollutants, Airborne Occupational Exposures, and Chronic Rhinosinusitis Disease Severity. Int. Forum Allergy Rhinol. 2020, 10, 175–182.
  11. Zheng, K.; Hao, J.; Xiao, L.; Wang, M.; Zhao, Y.; Fan, D.; Li, Y.; Wang, X.; Zhang, L. Expression of Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Chronic Rhinosinusitis with Nasal Polyps. Int. Forum Allergy Rhinol. 2020, 10, 646–655.
  12. Mihalj, H.; Butković, J.; Tokić, S.; Štefanić, M.; Kizivat, T.; Bujak, M.; Baus Lončar, M.; Mihalj, M. Expression of Oxidative Stress and Inflammation-Related Genes in Nasal Mucosa and Nasal Polyps from Patients with Chronic Rhinosinusitis. Int. J. Mol. Sci. 2022, 23, 5521.
  13. Zorlu, M.E.; Uygur, K.K.; Yılmaz, N.S.; Demirel, Ö.Ö.; Aydil, U.; Kızıl, Y.; Uslu, S. Evaluation of Advanced Oxidation Protein Products (AOPP) and Superoxide Dismutase (SOD) Tissue Levels in Patients with Nasal Polyps. Indian J. Otolaryngol. Head Neck Surg. 2022.
  14. Alhawiti, N.M.; Al Mahri, S.; Aziz, M.A.; Malik, S.S.; Mohammad, S. TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook. Curr. Drug Targets 2017, 18, 1095–1103.
  15. Lin, H.; Ba, G.; Tang, R.; Li, M.; Li, Z.; Li, D.; Ye, H.; Zhang, W. Increased Expression of TXNIP Facilitates Oxidative Stress in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis With Nasal Polyps. Am. J. Rhinol. Allergy 2021, 35, 607–614.
  16. Ramanathan, M.J.; Tharakan, A.; Sidhaye, V.K.; Lane, A.P.; Biswal, S.; London, N.R.J. Disruption of Sinonasal Epithelial Nrf2 Enhances Susceptibility to Rhinosinusitis in a Mouse Model. Laryngoscope 2021, 131, 713–719.
  17. London, N.R.J.; Tharakan, A.; Mendiola, M.; Sussan, T.E.; Chen, M.; Dobzanski, A.; Lane, A.P.; Sidhaye, V.; Biswal, S.; Ramanathan, M.J. Deletion of Nrf2 Enhances Susceptibility to Eosinophilic Sinonasal Inflammation in a Murine Model of Rhinosinusitis. Int. Forum Allergy Rhinol. 2019, 9, 114–119.
  18. London, N.R.J.; Tharakan, A.; Lane, A.P.; Biswal, S.; Ramanathan, M.J. Nuclear Erythroid 2-Related Factor 2 Activation Inhibits House Dust Mite-Induced Sinonasal Epithelial Cell Barrier Dysfunction. Int. Forum Allergy Rhinol. 2017, 7, 536–541.
  19. Nishida, M.; Takeno, S.; Takemoto, K.; Takahara, D.; Hamamoto, T.; Ishino, T.; Kawasumi, T. Increased Tissue Expression of Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Is Associated with Disease Severity in Chronic Rhinosinusitis with Nasal Polyps. Diagnostics 2020, 10, 246.
  20. Kawasumi, T.; Takeno, S.; Ishikawa, C.; Takahara, D.; Taruya, T.; Takemoto, K.; Hamamoto, T.; Ishino, T.; Ueda, T. The Functional Diversity of Nitric Oxide Synthase Isoforms in Human Nose and Paranasal Sinuses: Contrasting Pathophysiological Aspects in Nasal Allergy and Chronic Rhinosinusitis. Int. J. Mol. Sci. 2021, 22, 7561.
  21. Paoletti, G.; Casini, M.; Malvezzi, L.; Pirola, F.; Russo, E.; Nappi, E.; Quintina Muci, G.; Montagna, C.; Messina, M.R.; Ferri, S.; et al. Very Rapid Improvement of Extended Nitric Oxide Parameters, Associated with Clinical and Functional Betterment, in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Treated with Dupilumab. J. Investig. Allergol. Clin. Immunol. 2022, 33, 1–25.
  22. Jeruzal-Świątecka, J.; Borkowska, E.; Łaszczych, M.; Nowicka, Z.; Pietruszewska, W. TAS2R38 Bitter Taste Receptor Expression in Chronic Rhinosinusitis with Nasal Polyps: New Data on Polypoid Tissue. Int. J. Mol. Sci. 2022, 23, 7345.
  23. Cantone, E.; Negri, R.; Roscetto, E.; Grassia, R.; Catania, M.R.; Capasso, P.; Maffei, M.; Soriano, A.A.; Leone, C.A.; Iengo, M.; et al. In Vivo Biofilm Formation, Gram-Negative Infections and TAS2R38 Polymorphisms in CRSw NP Patients. Laryngoscope 2018, 128, E339–E345.
  24. Carey, R.M.; Hariri, B.M.; Adappa, N.D.; Palmer, J.N.; Lee, R.J. HSP90 Modulates T2R Bitter Taste Receptor Nitric Oxide Production and Innate Immune Responses in Human Airway Epithelial Cells and Macrophages. Cells 2022, 11, 1478.
  25. Workman, A.D.; Maina, I.W.; Brooks, S.G.; Kohanski, M.A.; Cowart, B.J.; Mansfield, C.; Kennedy, D.W.; Palmer, J.N.; Adappa, N.D.; Reed, D.R.; et al. The Role of Quinine-Responsive Taste Receptor Family 2 in Airway Immune Defense and Chronic Rhinosinusitis. Front. Immunol. 2018, 9, 624.
  26. Qu, J.; Mei, Q.; Niu, R. Oxidative CaMKII as a Potential Target for Inflammatory Disease (Review). Mol. Med. Rep. 2019, 20, 863–870.
  27. Wang, H.; Do, D.C.; Liu, J.; Wang, B.; Qu, J.; Ke, X.; Luo, X.; Tang, H.M.; Tang, H.L.; Hu, C.; et al. Functional Role of Kynurenine and Aryl Hydrocarbon Receptor Axis in Chronic Rhinosinusitis with Nasal Polyps. J. Allergy Clin. Immunol. 2018, 141, 586–600.
  28. Esen, E.; Selçuk, A.; Passali, D. Epidemiology of Nasal Polyposis. In All Around the Nose; Cingi, C., Bayar Muluk, N., Eds.; Springer International Publishing: Cham, Switzerland, 2020; pp. 367–371. ISBN 978-3-030-21217-9.
  29. Rajguru, R. Nasal Polyposis: Current Trends. Indian J. Otolaryngol. Head Neck Surg. 2014, 66, 16–21.
  30. Traina, G.; Bolzacchini, E.; Bonini, M.; Contini, D.; Mantecca, P.; Caimmi, S.M.E.; Licari, A. Role of Air Pollutants Mediated Oxidative Stress in Respiratory Diseases. Pediatr. Allergy Immunol. 2022, 33 (Suppl. S27), 38–40.
  31. Istratenco, A. Oxidative Stress-Related Pathophysiology in Chronic Rhinosinusitis with Nasal Polyps: Research Challenges. Rom. J. Rhinol. 2019, 9, 71–77.
  32. Cho, D.-Y.; Le, W.; Bravo, D.T.; Hwang, P.H.; Illek, B.; Fischer, H.; Nayak, J. V Air Pollutants Cause Release of Hydrogen Peroxide and Interleukin-8 in a Human Primary Nasal Tissue Culture Model. Int. Forum Allergy Rhinol. 2014, 4, 966–971.
  33. Holecek, V.; Rokyta, R.; Slipka, J. Free Radicals in Nasal and Paranasal Diseases. In Free Radicals in ENT Pathology; Miller, J., Le Prell, C.G., Rybak, L., Eds.; Springer International Publishing: Cham, Switzerland, 2015; pp. 479–492. ISBN 978-3-319-13473-4.
  34. Topal, O.; Kulaksızoglu, S.; Erbek, S.S. Oxidative Stress and Nasal Polyposis: Does It Affect the Severity of the Disease? Am. J. Rhinol. Allergy 2014, 28, e1–e4.
  35. Okur, E.; Gul, A.; Kilinc, M.; Kilic, M.A.; Yildirim, I.; Tolun, F.I.; Atli, Y. Trace Elements in Nasal Polyps. Eur. Arch. Oto-Rhino-Laryngol. 2013, 270, 2245–2248.
  36. Cheng, Y.-K.; Hwang, G.-Y.; Lin, C.-D.; Tsai, M.-H.; Tsai, S.-W.; Chang, W.-C. Altered Expression Profile of Superoxide Dismutase Isoforms in Nasal Polyps from Nonallergic Patients. Laryngoscope 2006, 116, 417–422.
  37. Cekin, E.; Ipcioglu, O.M.; Erkul, B.E.; Kapucu, B.; Ozcan, O.; Cincik, H.; Gungor, A. The Association of Oxidative Stress and Nasal Polyposis. J. Int. Med. Res. 2009, 37, 325–330.
  38. Sagit, M.; Erdamar, H.; Saka, C.; Yalcin, S.; Akin, I. Effect of Antioxidants on the Clinical Outcome of Patients with Nasal Polyposis. J. Laryngol. Otol. 2011, 125, 811–815.
  39. Simsek, F.; Eren, E.; Bahceci, S.; Aladag, I. High PI3K/MTOR and Low MAPK/JNK Activity Results in Decreased Apoptosis and Autophagy in Nasal Polyposis. Braz. J. Otorhinolaryngol. 2021, 87, 572–577.
  40. Sahiner, U.M.; Birben, E.; Erzurum, S.; Sackesen, C.; Kalayci, Ö. Oxidative Stress in Asthma: Part of the Puzzle. Pediatr. Allergy Immunol. 2018, 29, 789–800.
  41. Okeleji, L.O.; Ajayi, A.F.; Adebayo-Gege, G.; Aremu, V.O.; Adebayo, O.I.; Adebayo, E.T. Epidemiologic Evidence Linking Oxidative Stress and Pulmonary Function in Healthy Populations. Chronic Dis. Transl. Med. 2021, 7, 88–99.
  42. Ricciardolo, F.L.M.; Bertolini, F.; Carriero, V.; Sprio, A.E. Asthma Phenotypes and Endotypes. Minerva Med. 2021, 112, 547–563.
  43. Kleniewska, P.; Pawliczak, R. The Participation of Oxidative Stress in the Pathogenesis of Bronchial Asthma. Biomed. Pharmacother. 2017, 94, 100–108.
  44. Kuruvilla, M.E.; Lee, F.E.-H.; Lee, G.B. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin. Rev. Allergy Immunol. 2019, 56, 219–233.
  45. Gans, M.D.; Gavrilova, T. Understanding the Immunology of Asthma: Pathophysiology, Biomarkers, and Treatments for Asthma Endotypes. Paediatr. Respir. Rev. 2020, 36, 118–127.
  46. Jones, T.L.; Neville, D.M.; Chauhan, A.J. Diagnosis and Treatment of Severe Asthma: A Phenotype-Based Approach. Clin. Med. 2018, 18, s36–s40.
  47. Katial, R.K.; Bensch, G.W.; Busse, W.W.; Chipps, B.E.; Denson, J.L.; Gerber, A.N.; Jacobs, J.S.; Kraft, M.; Martin, R.J.; Nair, P.; et al. Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies. J. Allergy Clin. Immunol. Pract. 2017, 5, S1–S14.
  48. Chamitava, L.; Cazzoletti, L.; Ferrari, M.; Garcia-Larsen, V.; Jalil, A.; Degan, P.; Fois, A.G.; Zinellu, E.; Fois, S.S.; Fratta Pasini, A.M.; et al. Biomarkers of Oxidative Stress and Inflammation in Chronic Airway Diseases. Int. J. Mol. Sci. 2020, 21, 4339.
  49. Allam, V.S.R.R.; Paudel, K.R.; Gupta, G.; Singh, S.K.; Vishwas, S.; Gulati, M.; Gupta, S.; Chaitanya, M.V.N.L.; Jha, N.K.; Gupta, P.K.; et al. Nutraceuticals and Mitochondrial Oxidative Stress: Bridging the Gap in the Management of Bronchial Asthma. Environ. Sci. Pollut. Res. 2022, 29, 62733–62754.
  50. Liu, K.; Hua, S.; Song, L. PM2.5 Exposure and Asthma Development: The Key Role of Oxidative Stress. Oxid. Med. Cell. Longev. 2022, 2022, 3618806.
  51. Tiotiu, A.I.; Novakova, P.; Nedeva, D.; Chong-Neto, H.J.; Novakova, S.; Steiropoulos, P.; Kowal, K. Impact of Air Pollution on Asthma Outcomes. Int. J. Environ. Res. Public Health 2020, 17, 6212.
  52. Jesenak, M.; Zelieskova, M.; Babusikova, E. Oxidative Stress and Bronchial Asthma in Children—Causes or Consequences? Front. Pediatr. 2017, 5, 162.
  53. Xu, C.; Song, Y.; Wang, Z.; Jiang, J.; Piao, Y.; Li, L.; Jin, S.; Li, L.; Zhu, L.; Yan, G. Pterostilbene Suppresses Oxidative Stress and Allergic Airway Inflammation through AMPK/Sirt1 and Nrf2/HO-1 Pathways. Immunity, Inflamm. Dis. 2021, 9, 1406–1417.
  54. Yong, J.I.; Kim, D.W.; Shin, M.J.; Jo, H.S.; Park, J.H.; Cho, S.B.; Lee, C.H.; Yeo, H.J.; Yeo, E.J.; Choi, Y.J.; et al. PEP-1-PEA15 Suppresses Inflammatory Responses by Regulation of MAPK in Macrophages and Animal Models. Immunobiology 2018, 223, 709–717.
  55. Zhang, X.; Ding, M.; Zhu, P.; Huang, H.; Zhuang, Q.; Shen, J.; Cai, Y.; Zhao, M.; He, Q. New Insights into the Nrf-2/HO-1 Signaling Axis and Its Application in Pediatric Respiratory Diseases. Oxid. Med. Cell. Longev. 2019, 2019, 3214196.
  56. Li, J.; Wang, H.; Zheng, Z.; Luo, L.; Wang, P.; Liu, K.; Namani, A.; Jiang, Z.; Wang, X.J.; Tang, X. Mkp-1 Cross-Talks with Nrf2/Ho-1 Pathway Protecting against Intestinal Inflammation. Free Radic. Biol. Med. 2018, 124, 541–549.
  57. Wang, C.; Choi, Y.H.; Xian, Z.; Zheng, M.; Piao, H.; Yan, G. Aloperine Suppresses Allergic Airway Inflammation through NF-ΚB, MAPK, and Nrf2/HO-1 Signaling Pathways in Mice. Int. Immunopharmacol. 2018, 65, 571–579.
  58. Gu, X.; Zhang, Q.; Du, Q.; Shen, H.; Zhu, Z. Pinocembrin Attenuates Allergic Airway Inflammation via Inhibition of NF-ΚB Pathway in Mice. Int. Immunopharmacol. 2017, 53, 90–95.
  59. Yi, L.; Cui, J.; Wang, W.; Tang, W.; Teng, F.; Zhu, X.; Qin, J.; Wuniqiemu, T.; Sun, J.; Wei, Y.; et al. Formononetin Attenuates Airway Inflammation and Oxidative Stress in Murine Allergic Asthma. Front. Pharmacol. 2020, 11, 533841.
  60. Lim, J.-O.; Song, K.H.; Lee, I.S.; Lee, S.-J.; Kim, W.-I.; Pak, S.-W.; Shin, I.-S.; Kim, T. Cimicifugae Rhizoma Extract Attenuates Oxidative Stress and Airway Inflammation via the Upregulation of Nrf2/HO-1/NQO1 and Downregulation of NF-ΚB Phosphorylation in Ovalbumin-Induced Asthma. Antioxidants 2021, 10, 1626.
  61. Suzuki, M.; Cole, J.J.; Konno, S.; Makita, H.; Kimura, H.; Nishimura, M.; Maciewicz, R.A. Large-Scale Plasma Proteomics Can Reveal Distinct Endotypes in Chronic Obstructive Pulmonary Disease and Severe Asthma. Clin. Transl. Allergy 2021, 11, e12091.
  62. Saunders, R.M.; Biddle, M.; Amrani, Y.; Brightling, C.E. Stressed out—The Role of Oxidative Stress in Airway Smooth Muscle Dysfunction in Asthma and COPD. Free Radic. Biol. Med. 2022, 185, 97–119.
  63. Carpagnano, G.E.; Scioscia, G.; Lacedonia, D.; Soccio, P.; Quarato, C.M.I.; Cotugno, G.; Palumbo, M.G.; Foschino Barbaro, M.P. Searching for Inflammatory and Oxidative Stress Markers Capable of Clustering Severe Asthma. Arch. Bronconeumol. 2021, 57, 338–344.
  64. Lewis, B.W.; Ford, M.L.; Rogers, L.K.; Britt, R.D. Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD. Antioxidants 2021, 10, 1335.
  65. Enweasor, C.; Flayer, C.H.; Haczku, A. Ozone-Induced Oxidative Stress, Neutrophilic Airway Inflammation, and Glucocorticoid Resistance in Asthma. Front. Immunol. 2021, 12, 631092.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Public, Environmental & Occupational Health
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Martha Patricia Sierra-Vargas
,
Josaphat Miguel Montero-Vargas
,
Yazmín Debray-García
,
Juan Carlos Vizuet-de-Rueda
,
Alejandra Loaeza-Román
,
Luis M. Terán
View Times: 358
Revisions: 3 times (View History)
Update Date: 08 Feb 2023
Table of Contents
    1000/1000
    Hot Most Recent
    Feedback